In conclusion, an analysis of 1,815 consecutive GC cases revealed that patients with SALL4-positive GC experience significantly worse outcomes than SALL4-negative patients, indicating that SALL4 is a prognostic indicator in GC. Here, SALL4 is linked to gastric cancer.